Chemokine-extracellular matrix interactions as drivers of antimelanoma immunity

The Walter and Eliza Hall Institute of Medical Research, a foreign-owned non-profit organization based in Australia, received a $550,000 Project Grant from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to study chemokine-extracellular matrix interactions as drivers of anti-melanoma immunity. The 3-year award, effective September 30, 2023 through September 29, 2026, supports the Institute's medical research focused on cancer, immunity, and infectious diseases. The Institute has also managed sub-awards for genomics cores and next-generation sequencing related to malaria field studies in the Asia-Pacific region. Additionally, the organization has received other prime federal grants from agencies like the National Institutes of Health for research on topics such as lung cancer immunotherapy and Toxoplasma infections.